Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.17B |
| 2 |
Netflix
NFLX
|
+$753M |
| 3 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$749M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$662M |
| 5 |
Walmart Inc
WMT
|
+$405M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.08B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$426M |
| 3 |
Meta Platforms (Facebook)
META
|
+$372M |
| 4 |
TSMC
TSM
|
+$331M |
| 5 |
Pinduoduo
PDD
|
+$319M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.23% |
| 2 | Technology | 1.7% |
| 3 | Consumer Discretionary | 0.84% |
| 4 | Communication Services | 0.67% |
| 5 | Financials | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRCG
11876
Leverage Shares 2X Long CRCL Daily ETF
CRCG
$189M
| $29.9K | ﹤0.01% |
1,148
-1,363
| -54% | -$74.5K |
|
11877
MediciNova
MNOV
$70.4M
| $29.8K | ﹤0.01% |
22,753
-100,126
| -81% | -$138K |
|
11878
PDS Biotechnology
PDSB
$12.1M
| $29.7K | ﹤0.01% |
38,566
-55,778
| -59% | -$50.3K |
|
11879
CALL
Outdoor Holding Co
POWW
$254M
| $29.6K | ﹤0.01% |
17,300
+1,400
| +9% | +$2.41K |
|
11880
OmniAb
OABI
$670M
| $29.5K | ﹤0.01% |
15,958
+1,033
| +7% | +$1.79K |
|
|
ABVE
11881
CALL
DELISTED
Above Food Ingredients Inc
ABVE
| $29.5K | ﹤0.01% |
+18,100
| New | +$54.1K |
|
11882
HF Foods Group
HFFG
$96.5M
| $29.5K | ﹤0.01% |
13,721
-1,137
| -8% | -$2.74K |
|
|
NOTE
11883
CALL
DELISTED
FiscalNote
NOTE
| $29.4K | ﹤0.01% |
20,000
-90,500
| -82% | -$275K |
|
11884
SemiLEDS
LEDS
$16.5M
| $29.2K | ﹤0.01% |
+19,436
| New | +$43.8K |
|
11885
MaxCyte
MXCT
$133M
| $29.1K | ﹤0.01% |
18,769
+165
| +0.9% | +$264 |
|
11886
SOBR Safe
SOBR
$2.54M
| $28.5K | ﹤0.01% |
+13,309
| New | +$33.6K |
|
11887
PUT
Clean Energy Fuels
CLNE
$353M
| $28.4K | ﹤0.01% |
13,500
+900
| +7% | +$2.2K |
|
11888
Xtant Medical Holdings
XTNT
$47M
| $28.3K | ﹤0.01% |
+36,158
| New | +$26.3K |
|
|
ACH
11889
PUT
Accendra Health
ACH
$93.8M
| $28.3K | ﹤0.01% |
10,100
-113,600
| -92% | -$406K |
|
11890
CALL
ProQR Therapeutics
PRQR
$326M
| $28.3K | ﹤0.01% |
+14,000
| New | +$32.7K |
|
|
UFG
11891
Uni-Fuels Holdings
UFG
$17.9M
| $28K | ﹤0.01% |
+41,100
| New | +$43.3K |
|
11892
IRIDEX
IRIX
$12.4M
| $27.9K | ﹤0.01% |
24,487
-31,983
| -57% | -$32.9K |
|
|
ETS
11893
Elite Express Holding Inc
ETS
$41.4M
| $27.9K | ﹤0.01% |
+56,449
| New | +$36.5K |
|
|
QTEX
11894
QTREX Quantum
QTEX
$55.7M
| $27.8K | ﹤0.01% |
+30,884
| New | +$32.4K |
|
11895
CALL
Black Diamond Therapeutics
BDTX
$130M
| $27.5K | ﹤0.01% |
11,300
-57,400
| -84% | -$203K |
|
11896
PUT
Atomera
ATOM
$175M
| $27.4K | ﹤0.01% |
12,400
-24,100
| -66% | -$72.8K |
|
11897
CALL
IT Tech Packaging
ITP
$3.06M
| $27.1K | ﹤0.01% |
123,400
+85,100
| +222% | +$21K |
|
|
BNKK
11898
PUT
Bonk Inc
BNKK
$10.6M
| $27.1K | ﹤0.01% |
10,500
+10,023
| +2,101% | +$69.1K |
|
11899
Hyperfine
HYPR
$90.1M
| $27K | ﹤0.01% |
27,569
-2,664
| -9% | -$3.21K |
|
11900
Good Times Restaurants
GTIM
$15.8M
| $27K | ﹤0.01% |
+22,287
| New | +$31.2K |
|
Similar funds
Jeff Yass's Q4 2025 Portfolio in Review
As of Q4 2025, Jeff Yass held 14,094 positions worth $868B, down 0.79% from $875B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2025 filing shows 1,864 new, 4,890 increased, 5,380 reduced and 1,914 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,468,872 shares worth $124M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.08B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2025 buy was iShares Core MSCI Total International Stock ETF: 1,468,872 shares worth $124M.
- Jeff Yass added most to Invesco QQQ Trust in Q4 2025, an estimated $1.17B increase.
- Jeff Yass's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.08B.
- Jeff Yass fully exited Innovator US Equity Power Buffer ETF September in Q4 2025, selling an estimated $26.5M.
- Jeff Yass's ten largest holdings make up 24% of its $868B portfolio in Q4 2025.
- Jeff Yass opened 1,864 new positions and closed 1,914 in Q4 2025.
- Jeff Yass's portfolio value fell 0.79% quarter-over-quarter to $868B.
Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.